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Idiopathic sudden sensorineural hearing loss is a disease 
of unknown etiology. Controversy in the literature argues 
whether the condition should be treated by steroid 
therapy. In this case study, a Medline literature search 
was completed to find out if there is any evidence to 
support its use in this condition  . 
 
Case presentation 
A 37 year old man was referred to our emergency 
department by his general practitioner with a three day 
history of muffled hearing and tinnitus of the right ear. 
Symptoms were sudden onset, with no associated pain, 
dizziness or otorrhea and no past history of hearing 
problems or medical illness. Family history was negative 
and physical examination was normal. Otologic 
examination revealed normal tympanic membranes 
bilaterally, with no evidence of  cerumen or middle ear 
effusion. Tuning fork examination showed positive Rinne 
test bilaterally but with lateralization of Weber test to the 
left side, indicating right ear sensorineural hearing loss. 
Audiometric analysis confirmed sensorineural hearing loss 
across all frequencies of about 70-db in the right ear. 
Tympanometric analysis showed normal middle ear 
pressure and tympanic membrane compliance on both 
sides with no evidence of middle  ear effusion. Ear canal 
volume was normal indicating intact tympanic membranes 
bilaterally. Routine lab work including complete blood 
count, erythrocyte sedimentation rate, random glucose, 
urea, and electrolytes were all within normal limits. 
Magnetic resonance imaging of brain and internal auditory 
canal were also normal. 
 
Clinical diagnosis of idiopathic sudden sensorineural 
hearing loss of the right ear was made and the patient 
began a one week prednisone therapy of 60 mg daily to 
be tapered with a dose of 10 mg reduction every two days 
over the next ten days. The patient was followed for three 
months with repeat hearing assessment every two to four 
weeks. Unfortunately his hearing in the affected ear 
showed no significant improvement. He did not require a 
hearing aid since he had adequate hearing in the 
unaffected ear .   
 
The clinical question is; in patients with idiopathic 
sudden sensorineural hearing loss does the use of 
systemic corticosteroid therapy improve the chances of 
hearing recovery ?  
To answer the question; Medline was searched using 
the following strategies : 
 
Strategy 1:  the literature was searched using the 
keywords sudden hearing loss, sudden deafness, 
idiopathic sudden deafness, idiopathic sensorineural 
deafness, sudden sensorineural or sudden nerve deafness, 
idiopathic sudden sensorineural hearing loss, or idiopathic 
sudden nerve deafness  . 
Strategy 2:  the literature was again searched using the 
words corticosteroid(s), steroid, steroids,  glucocorticoid, 
or glucocorticoids . 
The combinations of strategy one and two identified 358 
papers. We attempted to identify papers using a high level 
of evidence and large sample size, excluding papers using 
direct injection of steroid into the middle ear via the 
tympanic membrane, a practice not widely used. We 
found five key papers which directly answered the 
question1-5. Only two of them were prospective trials 
[1,2]. 
 
The first compared the use of steroid or carbogen 
therapy against placebo in treating sudden sensorineural 
hearing loss [1] in a prospective double-blind study. The 
authors enrolled 41 patients with unexplained sudden 
sensorineural hearing loss who had no diabetes, previous 
ear conditions, or abnormal auditory physical findings. The 
outcome was measured through serial audiometric 
analysis of hearing levels at day six, with further follow-up 
assessment done at 90 days. The study showed no 
difference between early steroid or carbogen therapy. 
 
The second prospective study compared steroids to 
placebo [2]. It showed that steroids had a statistically 
significant effect on the recovery of moderate degree 
hearing loss. 
 
A Japanese retrospective, non-randomized, controlled 
study using chart review to assess the effectiveness of 
corticosteroids in treating sudden onset sensorineural 
hearing loss at lower frequencies reported improvement 
on audiogram in the corticosteroid treated group which 
was not statistically significant (P = 0.84) [3]. 
 
Another retrospective study of patients with sudden 
sensorineural hearing loss was reported4.  A group of 301 
patients who received no treatment over a period of six 
years were compared with 302 patients who had 
intravenous blood thinning drugs and glucocorticoid 
therapy.  Their objective criteria were hearing 
improvement evaluated by audiometric assessment. 
Results showed hearing recovery in both groups, however 
the group who received glucocorticoid treatment showed 
statistically significant hearing recovery at low and 
medium frequency range (P< 0.05). 
 
Another non-randomized, retrospective review of 
patients who presented with sudden sensorineural hearing 
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loss of unknown cause over a ten year period was 
reported5. It compared hearing outcomes of patients who 
received steroid therapy to those who received no steroid 
therapy. The key findings were in patients with severe 
sensorineural hearing loss.   It was found that steroid 
therapy significantly improved hearing recovery compared 
to those who received no steroid therapy (P< 0.01). The 
above effect was not found in patients with milder forms 
of hearing loss. Idiopathic sensorineural hearing loss 
mainly affects low frequencies, which is the normal speech 
frequency. 
 
Discussion 
The weakness of the first study was primarily small 
sample size [1]. The sample size required to achieve 
statistical significance was not calculated and the 
confidence interval was not done. The randomization was 
considered adequate because of the patient sequence 
numbering, and allocation of each patient in sequence to 
one of the four treatment groups. 
 
The conclusion of the second study can not be 
considered valid due to heavy contamination as well as 
bias [2]. They treated 33 patients versus 34 controls from 
the two different centres. Each centre was using a 
different type and dosage steroid regime. The authors 
added 52 patients who opted for no treatment to the 
control group assuming this group was similar to the 
placebo control.  Patients were removed from the 
treatment group and later included in the no-treatment 
group, affecting the validity of the results. So both the 
process of randomization and blinding were poorly 
conducted. This study did not account for all patients who 
decided to withdraw from the study, and intention to treat 
analysis was not completed. 
 
The third retrospective study had no control group [3]. 
There was a high possibility of contamination of the 
treatment group with a significant potential for 
confounding bias:  for example, using different 
medications for the treatment group. 
 
The fourth paper used non-homogenous study groups, 
and included patients with different disease pathology, i.e. 
diabetics, and ruptured round window membrane (in the 
glucocorticoid group) [4]. These were serious flaws 
significantly jeopardizing the validity of results. It was also 
a retrospective study lacking a control group or 
randomization, which detracts from the generalizability of 
any results. 
 
The fifth paper only reached the statistical significance 
level after excluding patients with low frequency hearing 
loss (speech frequency) and patients with milder forms of 
hearing loss in a second-pass analysis [5]. This has a high 
potential for exclusion bias. The control group was 
heterogeneous and included patients who did not want to 
receive treatment, were pregnant, or had medical 
contraindications to steroid therapy. 
 
In summary, idiopathic sudden sensorineural hearing 
loss is a condition of unknown etiology, affecting all age 
groups regardless of sex. So far in the literature there is 
no compelling evidence whether or not  steroid therapy 
should be used. Therefore further properly designed 
prospective, randomized, double blinded, controlled trials 
are required. Until then, we are of the opinion that 
patients should be offered a steroid therapy provided 
there are no contraindications. Full explanation about 
possible side effect of steroid to the patients is essential. 
 
References 
1. Cinamon U, Bendet E, Kronenberg J. Steroids, 
carbogen or placebo for sudden hearing loss: a 
prospective double-blind study. Eur Arch Otorhinolaryngol. 
2001; 258(9):477-480. 
2. Wilson WR, Byl FM, Laird N. The efficacy of steroids 
in the treatment of idiopathic sudden hearing loss: A 
double-blind clinical study. Arch Otolaryngol. 1980; 
106(12):772-776. 
3. Kitajiri S, Tabuchi K, Hiraumi H, Hirose T.  Is 
Corticosteroid therapy effective for sudden-onset 
sensorineural hearing loss at lower frequencies? Arch 
Otolaryngol Head Neck Surg. 2002; 128(4):365-367. 
4. Alexiou C, Arnold W, Fauser C, et.al. K.  Sensorineural 
hearing loss: does application of glucocorticoids make 
sense? Arch Otolaryngol Head Neck Surg. 2001; 
127(3):253-258 
5. Chen CY, Halpin C, Rauch SD. Oral steroid treatment 
of sudden sensorineural hearing loss: a ten year 
retrospective analysis. Otol Neurotol. 2003; 24(5):728-
733. 
 
Page 61